A controlled trial of colon bypass in chronic hepatic encephalopathy.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001927:Brain Diseases / Q000150:complications / Q000209:etiology* / Q000534:rehabilitation; D012809:Colon, Sigmoid / Q000601:surgery*; D004044:Dietary Proteins; D004569:Electroencephalography; D005260:Female; D006501:Hepatic Encephalopathy; D006801:Humans; D007082:Ileum / Q000601:surgery*; D008102:Liver Circulation; D008103:Liver Cirrhosis / Q000150:complications* / Q000601:surgery; D008111:Liver Function Tests; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008875:Middle Aged; D011168:Portal System; D011183:Postoperative Complications / Q000401:mortality; D011516:Prothrombin / Q000032:analysis; D012709:Serum Albumin / Q000032:analysis
D000900:Anti-Bacterial Agents; D004044:Dietary Proteins; D012709:Serum Albumin; D011516:Prothrombin; D001663:Bilirubin